Informations:
Erreur:
ID
39707
Description
Efficacy and Safety Study of DEB025/Alisporivir Combined to Peg-IFN and Ribavirin in Chronic Hepatitis C Genotype 1 Treatment-naïve Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01318694
Lien
https://clinicaltrials.gov/show/NCT01318694
Mots-clés
Versions (1)
- 11/02/2020 11/02/2020 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
11 février 2020
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Hepatitis C, Chronic NCT01318694
Eligibility Hepatitis C, Chronic NCT01318694
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01318694
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Hepatitis C, Chronic
Item
chronic hepatitis c viral
boolean
C0524910 (UMLS CUI [1])
Hepatitis C virus Genotype
Item
hcv genotype
boolean
C1533728 (UMLS CUI [1])
Prior Therapy Absent Hepatitis C
Item
no previous treatment for hepatitis c infection
boolean
C1514463 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])
Hepatitis C virus RNA assay Serum Quantitative Polymerase Chain Reaction
Item
serum hcv rna level ≥ 1000 iu/ml assessed by quantitative polymerase chain reaction or equivalent at screening, no upper limit
boolean
C1272251 (UMLS CUI [1,1])
C0229671 (UMLS CUI [1,2])
C1709846 (UMLS CUI [1,3])
C0229671 (UMLS CUI [1,2])
C1709846 (UMLS CUI [1,3])
Evaluation Liver | Biopsy of liver | Fibroscan
Item
liver evaluation prior to baseline: liver biopsy within 3 years or fibroscan within 6 months
boolean
C1261322 (UMLS CUI [1,1])
C0023884 (UMLS CUI [1,2])
C0193388 (UMLS CUI [2])
C4522043 (UMLS CUI [3])
C0023884 (UMLS CUI [1,2])
C0193388 (UMLS CUI [2])
C4522043 (UMLS CUI [3])
Hepatitis C virus genotype | HCV coinfection HCV Genotype Different
Item
hcv genotype different from genotype 1 or co-infection with other hcv genotype
boolean
C1533728 (UMLS CUI [1])
C1698259 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
C1705242 (UMLS CUI [2,3])
C1698259 (UMLS CUI [2,1])
C1533728 (UMLS CUI [2,2])
C1705242 (UMLS CUI [2,3])
HBV coinfection | HIV coinfection
Item
co-infection with hepatitis b or hiv
boolean
C2242656 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
C4062778 (UMLS CUI [2])
Liver disease | Etiology Except Hepatitis C virus
Item
any other cause of relevant liver disease other than hcv
boolean
C0023895 (UMLS CUI [1])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
C0015127 (UMLS CUI [2,1])
C0332300 (UMLS CUI [2,2])
C0220847 (UMLS CUI [2,3])
Hepatic decompensation
Item
presence or history of hepatic decompensation
boolean
C1394798 (UMLS CUI [1])
Alanine aminotransferase increased | Episode Quantity Elevated total bilirubin
Item
alt ≥ 10 times uln, more than 1 episode of elevated bilirubin (>uln) in past 6 months
boolean
C0151905 (UMLS CUI [1])
C0332189 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0741494 (UMLS CUI [2,3])
C0332189 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0741494 (UMLS CUI [2,3])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])